Preclinical Drug Product Applications

2 applications found

Human biology solutions for ADME-Tox sector

Accurate ADME-Tox profiling of preclinical drug candidates remains a challenge. Preclinical ADME-Tox (Absorption, Distribution, Metabolism, Excretion, and Toxicity) studies are pivotal to predicting human response. However, approximately 30% of drugs fail during human clinical trials due to adverse reactions despite promising preclinical study results, and another 60% fail due to lack of efficacy. ...

ByEmulate based in Boston, MASSACHUSETTS (USA)

Liposomes - Hollow Nanospheres for Cancer Therapy

The development of highly cytotoxic drugs is needed for the success of the treatment in tumor cells. Paradoxically, the high toxicity limits its efficacy and application in vivo, causing damage to non-target organs and severe secondary effects. The use of directed liposomes has allowed the advance of many cancer drugs to preclinical and clinical trials, reducing side effects, and increasing their therapeutic index at the same time. More than 15 cancer liposomed ...

ByNanovex Biotechnologies based in Llanera, SPAIN

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you